DOCATINUS
ActiveFinancials · financial year 2025, micro format
Annual accounts 2025 filed on 21-07-2026 at the NBB all 2 filings
Every figure per financial year
The operating result for 2025 is 75% higher than in 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 2024 | 2025 |
|---|---|---|
| Tangible fixed assets | €2,556 | €4,032 |
| Financial fixed assets | - | €0 |
| Depreciation and write-downs of the year | €134 | €598 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €134 | €598 | ▲ 348% |
| Other operating charges640/8 | - | €304 | - |
| Gross operating margin9900 | €19,423 | €34,712 | ▲ 78.7% |
| Operating profit (loss)9901 | €19,289 | €33,809 | ▲ 75.3% |
| Financial charges65/66B | - | €716 | - |
| Recurring financial charges65 | - | €716 | - |
| Profit (loss) for the period before taxes9903 | €19,289 | €33,094 | ▲ 71.6% |
| Income taxes67/77 | €4,275 | €7,222 | ▲ 68.9% |
| Profit (loss) for the period9904 | €15,014 | €25,872 | ▲ 72.3% |
| Profit (loss) for the period to be appropriated9905 | €15,014 | €25,872 | ▲ 72.3% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €48,156 | €78,114 | ▲ 62.2% |
| Fixed assets21/28 | €2,422 | €5,856 | ▲ 142% |
| Tangible fixed assets22/27 | €2,422 | €5,856 | ▲ 142% |
| Other tangible fixed assets26 | €2,422 | €5,856 | ▲ 142% |
| Current assets29/58 | €45,734 | €72,258 | ▲ 58.0% |
| Cash at bank and in hand54/58 | €23,146 | €46,621 | ▲ 101% |
| Deferred charges and accrued income490/1 | €22,588 | €25,637 | ▲ 13.5% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €48,156 | €78,114 | ▲ 62.2% |
| Equity10/15 | €17,014 | €42,886 | ▲ 152% |
| Contributions10/11 | €2,000 | €2,000 | = |
| Profit (loss) carried forward14 | €15,014 | €40,886 | ▲ 172% |
| Amounts payable17/49 | €31,142 | €35,228 | ▲ 13.1% |
| Amounts payable within one year42/48 | €31,142 | €35,228 | ▲ 13.1% |
| Trade debts44 | - | €271 | - |
| Suppliers440/4 | - | €271 | - |
| Taxes, remuneration and social security45 | €10,275 | €13,222 | ▲ 28.7% |
| Taxes450/3 | €10,275 | €13,222 | ▲ 28.7% |
| Other amounts payable47/48 | €20,867 | €21,735 | ▲ 4.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €15,014 | €25,872 | ▲ 72.3% |
| + Depreciation and write-downs630 | €134 | €598 | ▲ 348% |
| Operating cash flow (approximation) | €15,148 | €26,470 | ▲ 74.7% |
| Investment in fixed assets (approximation) | - | -€4,032 | - |
| Change in cash | - | €23,475 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 39,278 companies had the same profile as DOCATINUS has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of DOCATINUS itself: 0.6% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for DOCATINUS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.